EAU 2020: A Peek into the Future: Artificial Intelligence and Prostate Cancer Imaging

(UroToday.com) At the European Association of Urology (EAU) Virtual 2020 meeting, Dr. Olivier Rouviere concluded the plenary session on “Modern prostate cancer imaging in daily practice,”  by discussing the impact of artificial intelligence and prostate cancer imaging. Dr. Rouviere notes that machine learning entails training a machine to discriminate prostate cancer on magnetic resonance (MR) images using […]

EAU 2020: Recurrence after Radical Prostatectomy: Summary from the EAU Prostate Cancer Guidelines Panel

(UroToday.com) At the European Association of Urology (EAU) Virtual 2020 meeting, Dr. Nicolas Mottet, chair of the EAU Guidelines prostate cancer panel, summarized the guidelines for recurrence after radical prostatectomy. Dr. Mottet notes that there is a major difference between prostate-specific antigen (PSA) relapse (any PSA rise following an undetectable level) and a clinically significant PSA […]

EAU kicks off its first ever virtual Annual Congress

Today marks a new chapter for the European Association of Urology. For its 35th edition, the Annual EAU Congress is taking place not in a major European capital, but online. The scientific programme of the regular congress was re-arranged into a ten-day virtual congress following the cancellation of the regular congress. Thanks to innovative online congress […]

Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial.

This randomized, multicenter, placebo-controlled, phase IV study assessed the efficacy and tolerability of onabotulinumtoxinA in patients with overactive bladder. Patients were randomized 1:1 to onabotulinumtoxinA 100 U or placebo.

Rationale, design, and methods of electroencephalography-based investigation of the effects of oral desmopressin on improving slow-wave sleep time in nocturnal polyuria patients (the DISTINCT study): protocol for a single-arm, open-label, single-assignmen

Nocturia is one of the most bothersome lower urinary tract symptoms and often impairs sleep quality in the elderly. Although previous studies on nocturia have indicated that the successful treatment of nocturia improves sleep quality, most used questionnaires and activity devices to analyze sleep/wake patterns.

Monocentric single-arm study of desmopressin acetate efficacy on nocturnal polyuria in the elderly.

we designed a retrospective, monocentric, observational study to assess the short-term side effect profile of desmopressin, a synthetic analogue of antidiuretic hormone, in 42 elderly patients affected by nocturnal polyuria (NP), a subset of nocturia (nocturnal overproduction of urine at night), which is characterised by nocturnal urine volume (NVU) exceeding 33% of the 24-h total […]

X